Here are relevant reports on : pregnancy-test-kits-market

• HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030

  Global HIV diagnostics market valued at $2.96B in 2024, reached $3.25B in 2025, and is projected to grow at a robust 10.3% CAGR, hitting $ 5.31B by 2030. The HIV diagnostics market is driven by several key factors, such as the rising prevalence of HIV/AIDS, the increasing number of blood transfusions and blood donations, advantages offered by POC diagnostic kits & instruments, and the growing focus on initiatives for HIV awareness.

  • Published: February 2025
  • Price: $ 4950
  • TOC Available:

• Lateral Flow Assay Components Market by Type (Membrane, Pad), Application (Clinical Testing (Infectious, Cardiac Marker Test, Fertility, Pregnancy, Cholesterol Testing), Veterinary, Food Safety), Technique, End User & Region - Global Forecast to 2030

  The global lateral flow assay components market, valued at US$378.4 million in 2024, stood at US$392.4 million in 2025 and is projected to advance at a resilient CAGR of 4.4% from 2025 to 2030, culminating in a forecasted valuation of US$486.2 million by the end of the period. Market growth is driven by increasing health awareness and the shift toward lifestyle and home-based healthcare, as more consumers adopt self-monitoring and rapid testing solutions.

  • Published: September 2025
  • Price: $ 4950
  • TOC Available:

• North American Home Healthcare Market By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation Therapy] & Telehealth - Forecasts To 2017

  The North America home health care market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. Home healthcare market includes products, services, and telehealth. The home care product category comprises homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services.

  • Published: May 2013
  • Price: $ 4950
  • TOC Available:

• European Home Healthcare Market By Products (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit), Services (Respiratory Therapy, Rehabilitation Therapy) & Telehealth – Forecasts to 2017

  The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE).

  • Published: July 2013
  • Price: $ 4950
  • TOC Available:

• Urinalysis Market by Product (Consumables [Disposable, Reagents], Instruments [Automated, Microscopy, PoC]), Test Type (Pregnancy, Sediment), Application (UTI, Diabetes, CKD), Technology (Biochemical), End User (Hospital) & Region -Global Forecast to 2031

  The global urinalysis market is projected to reach USD 7.16 billion by 2031, growing at a CAGR of 8.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: August 2026
  • Price: $ 4950
  • TOC Available:

• Influenza Diagnostics Market by Product (Test Kits, Instruments), Test Type (Traditional (RIDT, Viral Culture, Serological), Molecular (PCR, INAAT- NASBAT, TMABAS)), End User (Diagnostic Laboratories, Hospitals, Clinics) & Region - Global Forecast to 2026

  The global influenza diagnostics market growth is primed to transition from $0.8 billion in 2021 to $1.1 billion by 2026, showcasing a strong CAGR of 7.7%. Key factors driving this growth include increasing demand for rapid disease diagnosis, rising influenza prevalence, and advancements in diagnostic technologies.

  • Published: September 2021
  • Price: $ 4950
  • TOC Available:

• Communication Test and Measurement Market by Type of Test (Enterprise Test, Field Network Test, Lab & Manufacturing Test, Network Assurance Test), Test Solution (Wireless Test Solution, Wireline Test Solution) - Global Forecast to 2032

  The communication test and measurement market is expected to reach USD 19.73 billion by 2032, from USD 11.37 billion in 2026, with a CAGR of 9.6%. Key players covered in the communication test and measurment market are Keysights Technologies (US), Rohde & Schwarz (Germany), Anritsu (Japan), Viavi Solutions (US), Yokogawa (Japan), Fortive (US), Exfo (Canada), Emerson (US), Huawei (China), Hammer (US), Calnex Solutions (UK), Luna Innovations (US), NetScout (US), Cisco (US), Litepoint (US), Sysmech (UK), Veex (US), Teoco Corporation (US), Netally (US), ThinkRF (Canada), Kyrio (US), Fastech Telecommunications (India), Eagle Photonics (India), and Verkotan (Finland).

  • Published: November 2026
  • Price: $ 7150
  • TOC Available:

• Biologics Safety Testing Market by Product (Kits, Reagents, Instruments), Services, Test Type (Mycoplasma, Sterility, Endotoxin, Bioburden), Product & Services by Application (Vaccines, mAbs, CGT), End User, Competition, Region - Global Forecast to 2031

  The global biologics safety testing market is projected to reach USD 9.66 billion by 2031, growing at a CAGR of 11.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: May 2026
  • Price: $ 4950
  • TOC Available:

• RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) & Region

  The global RSV diagnostics market is expected to grow at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).

  • Published: February 2018
  • Price: $ 4950
  • TOC Available:

• CT/NG Testing Market by Product (Assays, Kits & Analyzers), Test Type (Laboratory, Point-of-care Testing), Technology (INAAT, PCR, Immunodiagnostics), End User (Diagnostic Labs, Hospitals & Clinics) & Region - Global Forecast to 2028

  The global CT/NG testing market, valued at US$1.6 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.6% from 2023 to 2028, culminating in a forecasted valuation of US$2.7 billion by the end of the period. Market growth is largely driven by the increasing prevalence of CT/NG infections and the growing investments and funding for R&D in CT/NG diagnosis.

  • Published: July 2023
  • Price: $ 4950
  • TOC Available:

• NEXT
• LAST

Records 1 to 10 of 50